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Cell cultures of ovarian cystadenomas transfected with SV40 large T antigen are not immortal because they invariably reach a
phenomenon called crisis, which is triggered in part by telomere attrition. Recovery from crisis may be an integral component of the
malignant transformation process. We reported earlier that such ovarian cystadenoma cell cultures undergo severe changes in DNA
ploidy as they approach crisis and that such changes are an important determinant of crisis independent of telomere attrition. Here,
we show that in sharp contrast to these benign ovarian tumours, the DNA content of ovarian tumours of low malignant potential
(LMP) was remarkably stable as they approached crisis, suggesting that telomere attrition was the main determinant of this mortality
checkpoint. Lack of a ploidy-based crisis was not due to loss of expression of a functional SV40 large T antigen protein. We conclude
that ovarian LMP tumours are characterised by increased numerical chromosomal stability compared to cystadenomas. This might
account for the fact that most LMP tumours are diploid or near diploid in vivo. This fundamental difference in chromosomal stability
between ovarian cystadenomas and LMP tumours also suggests potential differences in predisposition to progression to malignancy
between these two ovarian tumour subtypes.
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The existence of a ‘semimalignant’ group of ovarian tumours was
first described by Taylor (1929). It took an additional 40 years
before such ovarian tumours, which are associated with a more
favourable prognosis than their frankly malignant counterparts
regardless of stage of presentation, became accepted as a clinical
entity (Santesson and Kottmeier, 1968; Aure et al, 1971). Both the
International Federation of Gynecology and Obstetrics (Serov et al,
1973) and the World Health Organization (Seidman et al, 2002)
currently classify ovarian epithelial tumours as benign (cystade-
nomas), malignant (carcinomas), and low malignant potential
(LMP, also called borderline). The latter is characterised by absent
or minimal invasive potential, although they can spread outside
the ovary and proliferate onto peritoneal surfaces. The exact
nature and malignant potential of these tumours has remained
controversial (Kurman and Trimble, 1993). They nevertheless
represent a good model to investigate the molecular determinants
of cancer development, because they show features that are
intermediate between those of clearly benign and clearly malignant
lesions.
Molecular genetic analyses performed over the last 15 years have
identified several changes that distinguish ovarian LMP tumours
from cystadenomas and carcinomas. For example, although
somatic loss of heterozygosity, a hallmark of malignancy, has
been occasionally observed in LMP tumours, it is clear that such
events are not only rare in these tumours, but are also not essential
to their development (Cheng et al, 1996). On the other hand, LMP
tumours usually express telomerase (Wan et al, 1997), a feature of
the malignant phenotype, and global DNA methylation changes
(Cheng et al, 1997) or changes in the DNA methylation status of
centromeric and juxtacentromeric sequences (Qu et al, 1999) in
these tumours are more similar to those in carcinomas than in
cystadenomas. Although these results strengthen the notion that
LMP tumours are intermediate between benign and frankly
malignant ovarian epithelial tumours, they shed little light on
their underlying mechanisms. Mutations in specific protein
kinases have been associated with LMP tumours and may be
more frequent in these tumours than in carcinomas (Mok et al,
1993; Teneriello et al, 1993; Cheng et al, 2004; Ho et al, 2004). Such
mutations are nevertheless seen in a large number of cancers of
various types as well as in ovarian cystadenomas and their
presence in LMP tumours sheds little light on the distinguishing
molecular features responsible for the phenotypic differences
between these tumours and either ovarian cystadenomas or
carcinomas.
One of the most distinguishing characteristics of the malignant
phenotype is the ability of cancer cells to proliferate indefinitely in
tissue culture environments. Cultures derived from normal cells,
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sin contrast, encounter mortality checkpoints after they have gone
through a set number of mitoses. The first mortality checkpoint
encountered by normal cells cultured in vitro, called senescence, is
characterised by growth arrest due to inhibition of the cell cycle,
whereas crisis, the next mortality checkpoint, is characterised by
increased apoptosis (Hara et al, 1991; Shay et al, 1991). Although
these phenomena have been observed primarily in vitro, it is likely
that escape or recovery from both checkpoints is also important
for the establishment of the malignant phenotype in vivo.W e
recently examined chromosomal changes associated with crisis in
ovarian cystadenoma cells cultured in vitro (Velicescu et al, 2003).
We used cells harbouring an expression vector for SV40 large T
antigen and were therefore able to bypass senescence, as this
antigen inhibits normal regulators of cell cycle activity. We showed
that crisis was triggered by two independent phenomena that
occurred sequentially in this cell culture system (Velicescu et al,
2003). The first was characterised by changes in DNA ploidy.
Those changes were so severe that 10 population doublings after
they became detectable by flow cytometry, the apoptotic pathways
triggered by those genomic changes had resulted in rates of cell
death that were higher than rates of cell proliferation. Cells that
recovered from this ploidy-based crisis resumed their logarithmic
growth, but eventually entered a second crisis state triggered by
telomere attrition (Velicescu et al, 2003).
Here, we show that cultured LMP tumour cells did not undergo
the severe ploidy changes that characterised cystadenomas as they
aged in vitro and thus were spared from a ploidy-dependent crisis.
Telomere attrition could be demonstrated in LMP tumours and
thus was probably the main determinant of crisis in those cells in
sharp contrast to cystadenomas. This genetic stability associated
with cultured LMP tumours might account for the fact that such
tumours tend to be diploid or near diploid in vivo. This
fundamental difference between benign ovarian epithelial tumours
and ovarian tumours of low malignant potential also suggests
differences in predisposition to progression to malignancy
between these two ovarian tumour subtypes.
MATERIALS AND METHODS
Cell lines and culture conditions
ML38 was derived from a mucinous LMP tumour. ML46 was
derived from a serous LMP tumour with invasive implants. Both
cell strains were isolated and infected with an adenovirus vector
expressing SV40 large T antigen using published protocols (Luo
et al, 1997). HOC-7 ovarian carcinoma cell line was obtained from
Dr Ronald N Buick, University of Toronto (Buick et al, 1985). The
source of ML10 was described earlier (Luo et al, 1997). ML38,
ML46 and ML10 cell strains were grown in MEM supplemented
with 10% FBS. HOC-7 cells were grown in RPMI supplemented
with 10% FBS.
Analysis of DNA ploidy by flow cytometry
One million cells were resuspended in phosphate-buffered saline
(PBS) followed by fixation in 70% ethanol. The cell pellets obtained
after centrifugation were resuspended in 1ml of PBS, 10mgml
 1
propidium iodide and 100mgml
 1 RNase. The DNA contents of
the cells were analysed using a Coulter Profile II flow cytometer
(Beckman Coulter, Hialeah, FL, USA) and analysed using the
MultiCycle software (Phoenix Flow Systems Inc., San Diego, CA,
USA).
Infection of cells with an adenoviral vector for SV40 large
T antigen
We added 7.5 10
7PFU of an adenoviral vector expressing SV40
large T antigen to 90% confluent cultures of LMP cell lines in
35-mm tissue culture dishes. The cells were re-infected 48h later.
The source of the vector was described earlier (Luo et al, 1997).
Western blot analysis
Cell monolayers were rinsed with 10ml of ice-cold PBS and treated
with ice-cold RIPA lysis buffer (20mM Tris–HCl (pH 8.0), 125mM
NaCl, 0.5% NP-40, 20mM NaF, 0.2mM Na3PO4,2 m M EDTA,
35mgml
 1 PMSF, 0.7mgml
 1 pepstatatin A, and 0.5mgml
 1
leupeptin) at 41C for 30min. They were detached from the tissue
culture dishes (Becton Dickinson Labware, Franklin Lakes, NJ,
USA) by rubbing with a cell lifter (Fisher Scientific, Pittsburgh, PA,
USA). After centrifugation at 12000rpm for 30min at 41C, the
supernatants were collected and stored at  801C. Protein
concentrations were determined using the BCA protein assay
reagent kit (Pierce, Rockford, IL, USA). Samples containing 10mg
of protein were electrophoresed on a 10% polyacrylamide gel and
transferred onto nitrocellulose membranes (Biorad Laboratories,
Richmond, CA, USA). The membrane was incubated overnight in
10% nonfat milk (Biorad Laboratories), 0.1% of PBS/Tween-20,
and exposed to primary antibody for 1h at room temperature.
Following three 10min washing in 0.1% PBS/Tween-20, the
membrane was exposed to the secondary antibody coupled to
horseradish peroxidase for 1h at room temperature. The signal
was detected by the ECL Western blotting detection reagents
(Amersham Biosciences, Buckinghamshire, England). For loading
control, the membrane was stripped in 100mM b-mercaptoethanol,
2% SDS, 62.5mM Tris–HCl (pH 6.7) at 651C for 30min, followed
by extensive washing in 0.1% of PBS/Tween-20, and reprobed with
monoclonal antibody against b-actin (Sigma, Saint Louis, MO,
USA). The monoclonal antibody against SV40 large T antigen was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA; cat
no sc-147).
Immunoprecipitation with p53 antibody
Two microgram of anti-p53 monoclonal antibody (Santa Cruz
Biotechnology) was added to 500mg of total cellular protein extract
(previously cleared by centrifugation) in a 1.5ml microcentrifuge
tube and incubated at 41C for 2h. Fifty microlitre of resuspended
protein A-agarose was added and incubated at 41C on a rocker
overnight. Immunoprecipitates were collected by centrifugation at
2500rpm for 5min at 41C. The supernatant was aspirated and the
pellet was washed four times with 1.0ml RIPA buffer (20mM Tris–
HCl (pH 8.0), 125mM NaCl, 0.5% NP-40, 20mM NaF, 0.2mM
Na3PO4,2m M EDTA, 35mgml
 1 PMSF, 0.7mgml
 1 pepstatatin A,
and 0.5mgml
 1 leupeptin), resuspended in 20mlo f
2 electrophoresis sample buffer, and heated in boiling water
for 2–3min. After removing the agarose beads by centrifugation,
20ml aliquots of supernatant were electrophoresed on SDS-
polyacrylamide gels followed by Western blotting with a mono-
clonal antibody against SV40 large T Antigen.
Determination of telomere length by Southern blotting
Ten microgram of genomic DNA were digested with RsaI/HinfI
restriction endonucleases, electrophoresed in 1% agarose gels, and
transferred onto Zeta Probe GT membranes (BioRad Laboratories,
Hercules, CA, USA) in 0.4M NaOH following acid depurination in
0.4N HCl. The probe, which consisted in a synthetic fragment
containing three repeats of the human telomeric sequence
TTAGGG, was end labelled with U-
32P-dCTP. The membrane was
hybridised in 0.5M NaHPO4 (pH 7.2), 5% SDS, 1mM EDTA (pH
8.0), 1% BSA, 50% formamide at 421C overnight following pre-
hybridisation for 1h under the same conditions. The membrane
was then washed for 15min at 421Ci n2 SSC, 1% SDS, followed
by washing with 0.2 SSC, 1% SDS for 15min at room
temperature. The hybridisation signals were visualised by ex-
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sposure to a phosphoimager (Model GS-525, Molecular Imager
s
System, BioRad Laboratories).
Detection of telomerase activity
Telomerase activity was measured using the Telomerase Repeat
Amplification Protocol (TRAP) as described previously (Velicescu
et al, 2003). Extracts from an immortal cell line (HOC-7) (Buick
et al, 1985) were used as positive control.
RESULTS
Differences in ploidy stability between ovarian
cystadenomas and LMP tumours expressing SV40 large
T antigen
Cultures of ovarian cystadenomas expressing SV40 large T antigen
typically develop severe ploidy changes as they age in culture
(Velicescu et al, 2003). We reported earlier that such changes in
DNA content, and not telomere attrition, are primarily responsible
for the initiation of crisis in these cells (Velicescu et al, 2003). We
sought to determine whether ploidy changes also occurred in
cultures derived from ovarian LMP tumours isolated using a
similar protocol and harbouring the same SV40 large T antigen
expression vector. Three cell cultures, one derived from an ovarian
cystadenoma called ML10 and two derived from LMP tumours,
respectively, called ML38 and ML46, were analysed for cellular
DNA content by flow cytometry either during their logarithmic
growth phase (Figure 1A, top panels) or as they approached crisis
(Figure 1A, bottom panels). This pre-crisis period in each culture
was determined based on reduced average population doubling
rates and on the presence of an increasing number of swollen or
floating cells in the culture dishes. Although most of the ML10 cells
were near tetraploid, as they approached crisis in agreement with
our earlier report based on observations of three different
cystadenoma cell strains (Velicescu et al, 2003), the two cultures
derived from LMP tumours showed little changes in their DNA
content throughout their crisis phase. The near diploid status of
ML38 and ML46 cells and the near tetraploid status of ML10 cells
approaching crisis was also confirmed by counting the number of
metaphase chromosomes in each cell line (data not shown).
Further evidence that the ML38 and ML46 cells shown in Figure 1
had indeed entered a crisis phase after 38 and 54 population
doublings comes from the increased number of cells with a DNA
content less than 2n, a sign of apoptosis, seen in the respective
panels (Figure 1A) as well as from the demonstration of increased
expression levels of p21, another marker of crisis, as shown in
Figure 1B for ML46.
Absence of ploidy changes in LMP tumours approaching
crisis is not due to loss of a functional SV40 large T antigen
It is well known that cells expressing SV40 large T antigen typically
develop changes in their DNA ploidy similar to those observed in
P21
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Figure 1 Influence of crisis on DNA content in ovarian cystadenoma vs
LMP tumour cells cultured in vitro. In vitro cultures derived from either an
ovarian cystadenoma (ML10) or from LMP tumours (ML38 and ML46)
were harvested by trypsinisation, stained with propidium iodine, and
analysed by flow cytometry at the indicated ages measured in population
doublings (PDs) (A). In each case, the lower population doubling number
represents cells growing logarithmically, whereas the higher population
doubling number represents cells approaching crisis. Further evidence that
the cells that reached the higher number of population doublings were in
crisis can be obtained from the increased number of cells undergoing
apoptosis seen on the DNA profiles in (A) or from demonstration of
increased expression of p21 protein by Western blotting shown for ML46
in (B) and compared to expression of b-actin used as loading control.
-Actin
-Actin
ML38 A
+ B
ML10 ML46
SV40 large T Ag 
(94 kDa)
−
SV40 large T Ag 
(94 kDa)
Figure 2 SV40 large T antigen expression in LMP tumour cells. (A)
Protein extracts were obtained from ML10, ML38, and ML46 cells and
analysed by Western blotting using antibodies against either SV40 large T
antigen or b-actin. (B) ML46 cells that had undergone 44 population
doublings in culture were either not re-infected ( ) or re-infected (þ)
with the adenoviral vector for SV40 large T antigen and analysed as they
approached crisis 10 population doublings later by Western blotting with
the same antibodies and by flow cytometry following staining with
propidium iodide.
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sovarian cystadenoma cell strains such as ML10. We therefore
considered the possibility that the notable lack of ploidy
alterations in cultures of LMP tumours could be due to either
loss of the SV40 large T antigen vector or to silencing of this vector
from either mutation or DNA methylation changes. We compared
the levels of this antigen in ML10, ML38, and ML46 cells by
Western blot analysis. The results showed expression of this
protein in all cell lines (Figure 2A), ruling out the possibility of
complete loss of the vector in the cells derived from LMP tumours.
We re-infected ML46 cells with our adenovirus vector expressing
SV40 large T antigen, because we noted that the amounts of T
antigen protein present in both LMP tumour cell strains were
lower than in ML10. Although this resulted in a substantial
increase in the levels of intracellular T antigen protein that was still
apparent 10 population doublings later (Figure 2B), there were no
significant differences in DNA content between cells not subjected
vs subjected to re-infection with the adenoviral vector at this time
point (Figure 2B). We conclude that reduced SV40 large T antigen
expression in ML38 and ML46 did not account for the relative
stability of their DNA content compared to ML10 cells. The reason
for the lower total levels of this antigen in ML38 and ML46 cells
when compared to ML10 may, in part, be due to the increased gene
dosage in ML10 due to increased DNA ploidy in the pre-crisis
period.
The possibility remained that the SV40 large T antigen
expressed in the LMP cell lines had reduced activity due to the
presence of a mutation. We therefore determined whether the T
antigen protein expressed in both cell lines had retained its ability
to bind to p53. Binding to this protein is an important determinant
of the consequences of T antigen expression on cell cycle activity.
Whole-cell extracts of ML38 and ML46 were immunoprecipitated
with anti-p53 antibody and the resulting precipitates were analysed
by Western blotting using an anti-large T antigen antibody. The
results (Figure 3) confirmed that the T antigen protein had
coprecipitated with p53 in ML10, ML38, and ML46 cells. There was
no detectable level of T antigen in HOC-7 ovarian carcinoma cells,
which were used as control. Although the levels of T antigen that
coprecipitated with p53 in the experiment shown in Figure 3
appeared lower in ML38 cells than in ML10 cystadenoma cells,
coprecipitation nevertheless did occur in those cells and the levels
in ML46 were similar to those present in ML10. We conclude that
the relative ploidy stability of the LMP cell lines is not due to
absence of a functional SV40 large T antigen, at least based on
ability of this antigen to bind to p53.
Telomere length in cultured LMP cells
We previously showed that telomere attrition is not the main
determinant of crisis in cultured ovarian cystadenoma cells,
because these cells characteristically show telomeres of a length
sufficient to support further chromosome replication by the time
they reach crisis (Velicescu et al, 2003). It is the severe ploidy
changes that invariably accumulate in these cells that trigger the
phenotypic manifestations of crisis, in part via induction of p21
resulting in increased apoptosis (Velicescu et al, 2003). Our earlier
study further showed that telomere attrition only became
significant in cystadenoma cells that had recovered from
this ploidy-based crisis (Velicescu et al, 2003). It is likely that,
unlike in cystadenomas, crisis is predominantly determined by
telomere attrition in LMP tumours, because DNA content in
those cells is more stable, depriving them of a stimulus for a
ploidy-based crisis. We performed Southern blotting analyses
of genomic DNA extracted from ML38 and ML46 cells of different
ages to examine the extent of telomere attrition in those cells.
As expected, there was a progressive shortening of telomere
length seen in ML38 cells at the various time points examined
(Figure 4). In addition, although sufficient quantities of ML46
DNA could not be obtained at 54 population doublings, because
of extensive apoptosis, telomere attrition was already evident in
those cells at 40 population doublings (Figure 4A). In addition,
none of the two LMP cell cultures expressed telomerase activity
detectable by the TRAP assay protocol (Figure 4B). Taken together,
these results suggest that cultured LMP cells do not have the ability
to maintain telomere length and presumably undergo a telomere-
driven crisis.
DISCUSSION
Our results clearly show that cultures of ovarian LMP tumour cells
expressing SV40 large T antigen remained diploid and showed
remarkable stability in their ploidy status throughout their in vitro
life span. This was in sharp contrast to cultures of ovarian
cystadenomas expressing the same antigen and isolated using
similar protocols, which typically become polyploid and eventually
aneuploid as they approach the phenomenon of in vitro crisis as
demonstrated in a previous report (Velicescu et al, 2003) and
illustrated again in this paper using a representative cystadenoma
cell strain. These differences were not due to loss of a functional
SV40 large T antigen in the cultures of LMP tumours. Given that
only two LMP tumour cell lines were available for these studies, the
generality of those differences between cystadenomas and LMP
tumours has not been established. However, if verified in a larger
population of LMP tumours, these results point to a fundamental
difference between ovarian cystadenomas and LMP tumours, with
important implications on the genetic stability of these ovarian
tumour subtypes.
Most LMP tumours express telomerase in vivo, providing an
additional argument in support of the notion that they represent a
stage of malignant transformation that is distinct from cystade-
nomas (Wan et al, 1997). Given that telomere attrition is thought
to be associated with structural chromosomal instability that can
be overcome by telomerase (Counter et al, 1992; Artandi et al,
2000; O’Hagan et al, 2002), one may question whether the
increased stability observed in our cultured LMP tumour cells
could have been due to varying levels of telomerase expression.
However, LMP tumour cell lines do not maintain telomerase
expression once put in culture. We not only have been unable to
detect telomerase activity in cultured LMP tumour cells using the
TRAP assay, but also the cells underwent telomere attrition
culminating in crisis. Thus, the mechanism responsible for the
increased stability seen in cultured LMP tumour cells appears to be
independent of telomerase activity. A better understanding of the
mechanisms underlying the apparent intrinsic genomic stability
associated with LMP tumours might provide insights into
molecular markers that could potentially help in the histopatho-
logical diagnosis of LMP tumours.
Hoc-7 ML10 ML38 ML46 RIPA
SV40 large T Ag 
(94 kDa)
Figure 3 SV40 large T antigen expressed in LMP tumour cells is
functional. Protein extracts from HOC-7 ovarian carcinoma cells, ML10,
ML38, and ML46 cells were immunoprecipitated with a monoclonal
antibody against p53 and analysed by Western blotting using a monoclonal
antibody against SV40 large T antigen. As control, immunoprecipitation
with anti-p53 was performed on a buffer sample containing no protein
extract (RIPA).
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sAcquisition of replicative immortality is an essential component
of the malignant phenotype. It is likely that the phenomena of
senescence and crisis are not mere in vitro curiosities, but also
have in vivo counterparts that need to be overcome during the
process of cancer development. Our results suggest that LMP
tumours, but not cystadenomas, may have developed a mechanism
that protects them against numerical chromosomal instability,
allowing these tumours to overcome at least one of the road blocks
to replicative immortality that operates in cystadenomas. This
might account for the fact that the large majority of these tumours
are diploid or nearly diploid in vivo, in spite of their rapid
proliferation rate (Friedlander et al, 1984; Lai et al, 1996). In fact,
aneuploid LMP tumours are associated with a more aggressive
clinical course (Kaern et al, 1990; Lai et al, 1996; Sykes et al, 1997)
and their response to chemotherapeutic agents may be more
typical of ovarian carcinomas (Kaern et al, 1990; Burger et al,
2000), raising the possibility that at least some of the those
tumours are carcinomas incorrectly diagnosed as LMP tumours.
Indeed, the possibility of using ploidy status as a diagnostic tool to
help distinguishing ovarian LMP tumours from carcinomas has
been suggested (Friedlander et al, 1984).
We reported earlier that, although p53 mutations are rare in
solitary cystadenomas, such mutations, when present, are con-
cordant in both components of heterogeneous tumours charac-
terised by a clearly malignant portion contiguous to a
morphologically benign lesion (Zheng et al, 1995). This, as well
as other observations (Zheng et al, 1993), led us to conclude that
ovarian cystadenomas are unlikely to progress spontaneously to
carcinoma unless predisposing changes such as a p53 mutation are
present. The cell culture system used in our study, which is based
on cells expressing SV40 large T antigen, is relevant to this
scenario because this antigen is known to inactivate p53, resulting
in the equivalent of a p53 mutation. The fact that cystadenomas
expressing SV40 large T antigen are prone to numerical
chromosomal instability, whereas LMP tumours expressing the
same antigen are stable with regard to their ploidy status suggests
that specific genetic alterations such as p53 mutations are more
likely to lead to progression to a malignant lesion when they occur
in cystadenomas compared to LMP tumours. Moreover, if an LMP
tumour does progress to malignancy, the resulting carcinoma
might be more likely to remain diploid or near diploid, implying a
lower histological grade. This idea supports the conclusion of Shih
and Kurman, who suggested that low-grade ovarian serous
carcinomas, but not high-grade carcinomas, may develop in pre-
existing LMP tumours (Shih and Kurman, 2005).
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